Pancreatic Cancer Research

Clinical trialNARecruiting

Clinical Study of Carbon Ion Radiotherapy for Pancreatic Cancer.

Single-arm Clinical Study of Carbon Ion Radiotherapy Combined with Nituzumab and Gemcitabine for Pancreatic Cancer.

NCT06840067↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
1 March 2025
Expected end
31 December 2028
Enrollment
62 participants
Sites
1
Primary outcomes
overall survival
Sponsor
Other
Results posted
No
Last update
25 March 2025

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 8